News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,573 Results
Type
Article (969)
Company Profile (11)
Press Release (74593)
Section
Business (21251)
Career Advice (129)
Deals (8327)
Drug Development (6711)
Employer Resources (2)
FDA (1324)
Job Trends (1561)
News (38134)
Policy (2768)
Tag
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (88)
Allergies (2)
Alliances (5919)
ALS (8)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (3)
Approvals (1335)
Artificial intelligence (6)
Automation (2)
Bankruptcy (84)
Best Places to Work (1392)
Biosimilars (9)
Biotechnology (7)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (19)
Cancer (196)
Cardiovascular disease (7)
Career advice (110)
CAR-T (7)
Cell therapy (27)
Cervical cancer (1)
Clinical research (5685)
Collaboration (55)
Compensation (23)
COVID-19 (92)
C-suite (23)
Cystic fibrosis (10)
Data (204)
Depression (3)
Diabetes (19)
Diagnostics (690)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (7458)
Employer branding (1)
Employer resources (2)
Events (10323)
Executive appointments (95)
FDA (1435)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (81)
Gene editing (3)
Gene therapy (8)
GLP-1 (24)
Government (192)
Guidances (3)
Healthcare (1995)
Immunology and inflammation (4)
Indications (2)
Infectious disease (102)
Inflammatory bowel disease (15)
Influenza (5)
Intellectual property (10)
Interviews (23)
IPO (4859)
Job creations (208)
Job search strategy (93)
Layoffs (8)
Legal (900)
Liver cancer (3)
Lung cancer (35)
Lymphoma (10)
Manufacturing (16)
MASH (6)
Medical device (1815)
Medtech (1815)
Mergers & acquisitions (3721)
Metabolic disorders (41)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (183)
NextGen: Class of 2025 (905)
Non-profit (163)
Northern California (244)
Obesity (17)
Opinion (2)
Ovarian cancer (6)
Pain (9)
Pancreatic cancer (17)
Parkinson's disease (19)
Partnered (3)
Patents (32)
Patient recruitment (11)
Peanut (2)
People (6561)
Pharmacy benefit managers (1)
Phase I (1761)
Phase II (2635)
Phase III (1859)
Pipeline (141)
Policy (1)
Postmarket research (146)
Preclinical (678)
Press Release (1)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (44)
Rare diseases (27)
Real estate (525)
Recruiting (1)
Regulatory (1841)
Reports (5)
Research institute (136)
Resumes & cover letters (15)
RSV (3)
Schizophrenia (10)
Series A (6)
Series B (7)
Sickle cell disease (8)
Southern California (284)
Spinal muscular atrophy (2)
Startups (496)
State (1)
Stomach cancer (1)
Supply chain (5)
United States (3005)
Vaccines (23)
Weight loss (2)
Date
Today (2)
Last 7 days (45)
Last 30 days (272)
Last 365 days (3992)
2025 (1040)
2024 (4448)
2023 (5505)
2022 (6722)
2021 (7859)
2020 (7555)
2019 (5271)
2018 (4084)
2017 (3918)
2016 (3233)
2015 (4529)
2014 (3094)
2013 (2533)
2012 (2710)
2011 (2362)
2010 (2113)
Location
Africa (20)
Alabama (2)
Arizona (23)
Arkansas (1)
Asia (3703)
Australia (469)
California (689)
Canada (144)
China (29)
Colorado (21)
Connecticut (45)
Delaware (12)
Europe (5227)
Florida (146)
Georgia (23)
Idaho (7)
Illinois (57)
India (1)
Indiana (55)
Japan (10)
Kansas (19)
Kentucky (1)
Maine (35)
Maryland (96)
Massachusetts (441)
Michigan (60)
Minnesota (42)
Mississippi (2)
Missouri (11)
Montana (2)
Nebraska (3)
Nevada (23)
New Hampshire (9)
New Jersey (265)
New Mexico (2)
New York (283)
North Carolina (184)
Northern California (244)
Ohio (29)
Oregon (2)
Pennsylvania (194)
Rhode Island (3)
South America (64)
South Carolina (6)
Southern California (284)
Tennessee (23)
Texas (160)
Utah (40)
Virginia (23)
Washington D.C. (1)
Washington State (52)
West Virginia (1)
Wisconsin (11)
75,573 Results for "hemogenyx llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
October 2, 2024
·
6 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000
January 8, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
December 30, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing
December 19, 2024
·
5 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 6, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
1 of 7,558
Next
